SOPH logo

SOPHiA GENETICS SA (SOPH)

Profile

Full Name

SOPHiA GENETICS SA

Ticker Symbol

SOPH

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

Switzerland

IPO

July 23, 2021

Indexes

Not included

Website

http://www.sophiagenetics.com

Employees

423

Key Details

Price

$2.88(+3.23%)

Market cap

$192.47M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$65.17M(+4.49% YoY)

Annual EPS

-$0.95(+22.13% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.88
SOPH price is $2.88

30-Day Relative Volume

0.62
SOPH 30-day relative volume is 0.62

Price Performance

Price Most recent change

+3.23%
SOPH price was up +3.23% on Apr 11, 2025

Price YTD change

-6.19%
SOPH price is down -6.19% since January 1st

Price 1-year change

-42.4%
SOPH price is down -42.4% year-on-year

Price 3-year change

-55.49%
SOPH price is down -55.49% over the past 3 years

Price Range

Price All-time high

$19.80
SOPH price is currently -85.45% below its historical high of $19.80

Price 3-year low

$1.69
SOPH price is currently +70.92% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$192.47M
SOPH market capitalization is $192.47 million

Market cap 3-year change

-53.46%
SOPH market capitalization is down -53.46% over the past 3 years

Market cap All-time high

$1.26B
SOPH market capitalization is currently -84.75% below its historical high of $1.26 billion

Market cap sector rank

56.94%
SOPH market capitalization is higher than 56.94% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.23%
SOPH shares outstanding is up +2.23% year-on-year

Shares Outstanding 3-Year Change

+4.56%
SOPH shares outstanding is up +4.56% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.88
SOPH beta is 0.88

200-day SMA

$3.64
SOPH price is currently -20.94% below its 200-day simple moving average

50-day SMA

$3.42
SOPH price is currently -15.84% below its 50-day simple moving average

RSI

43.67
SOPH 14-day relative strength index is 43.67

Volume

0.62
SOPH 30-day relative volume is 0.62

ATR

$0.37
SOPH average true range is $0.37

10-day Historical Volatility

95.16%
SOPH 10-day historical volatility is 95.16%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$65.17M
SOPH annual revenue is $65.17 million

Revenue Analysts estimate

$73.48M
SOPH annual revenue is currently -11.31% lower than the consensus analysts' forecast

Revenue 1-year change

+4.49%
SOPH annual revenue is up +4.49% year-on-year

Revenue Sector rank

50.95%
SOPH annual revenue is higher than 50.95% of companies in Healthcare sector

EPS

EPS

-$0.95
SOPH annual earnings per share is -$0.95

EPS Analysts estimate

-$0.65
SOPH annual earnings per share is currently +46.15% higher than the consensus analysts' forecast

EPS 1-year change

+22.13%
SOPH annual earnings per share is up +22.13% year-on-year

EPS Sector rank

57.8%
SOPH annual earnings per share is higher than 57.8% of companies in Healthcare sector

Profit

Gross profit

$43.94M
SOPH annual gross profit is $43.94 million

Gross margin

67.42%
SOPH annual gross profit margin is 67.42%

Operating profit

-$66.57M
SOPH annual operating income is -$66.57 million

Operating margin

-102.14%
SOPH annual operating profit margin is -102.14%

Net income

-$62.49M
SOPH annual net profit is -$62.49 million

Net margin

-95.89%
SOPH annual net profit margin is -95.89%

Expenses

Total expenses

$131.74M
SOPH annual total expenses is $131.74 million

Operating expenses

$110.50M
SOPH annual total operating expenses is $110.50 million

Cost of goods sold

$21.24M
SOPH annual cost of goods sold is $21.24 million

Selling, general & administrative expenses

$76.32M
SOPH annual SGA is $76.32 million

Depreciation and amortization

$8.60M
SOPH annual depreciation & amortization is $8.60 million

Interest expense

$1.91M
SOPH annual interest expense is $1.91 million

Income tax

$1.22M
SOPH annual income tax is $1.22 million

EBIT & EBITDA

EBIT

-$59.36M
SOPH annual earnings before interest & taxes is -$59.36 million

EBITDA

-$50.76M
SOPH annual EBITDA is -$50.76 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$155.31M
SOPH annual total assets is $155.31 million

Non current assets

$55.90M
SOPH annual long term assets is $55.90 million

Current assets

$99.41M
SOPH annual total current assets is $99.41 million

Cash and cash equivalents

$80.23M
SOPH annual cash & cash equivalents is $80.23 million

Accounts receivable

$7.09M
SOPH annual accounts receivable is $7.09 million

Inventory

$5.87M
SOPH annual inventory is $5.87 million

Liabilities

Total liabilities

$58.82M
SOPH annual total liabilities is $58.82 million

Long term liabilities

$32.02M
SOPH annual total long term liabilities is $32.02 million

Current liabilities

$26.80M
SOPH annual total current liabilities is $26.80 million

Accounts payable

$1.93M
SOPH annual accounts payable is $1.93 million

Debt

Total debt

$30.03M
SOPH annual total debt is $30.03 million

Total debt 1-year change

+61.44%
SOPH annual total debt is up +61.44% year-on-year

Long term debt

$27.84M
SOPH annual long term debt is $27.84 million

Short term debt

$2.19M
SOPH annual short term debt is $2.19 million

Equity & Capital

Shareholders equity

$96.49M
SOPH annual stockholders equity is $96.49 million

Book value

$96.49M
SOPH annual book value is $96.49 million

Retained earnings

-$440.28M
SOPH annual retained earnings is -$440.28 million

Working capital

$72.60M
SOPH annual working capital is $72.60 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$42.82M
SOPH annual cash flow from operations is -$42.82 million

Cash from operations 1-year change

+11.84%
SOPH annual cash flow from operations is up +11.84% year-on-year

Cash from investing

-$8.18M
SOPH annual cash flow from investing activities is -$8.18 million

Cash from investing 1-year change

-198.27%
SOPH annual cash flow from investing activities is down -198.27% year-on-year

Cash from financing

$11.59M
SOPH annual cash flow from financing activities is $11.59 million

Cash from financing 1-year change

+511.25%
SOPH annual cash flow from financing activities is up +511.25% year-on-year

CAPEX

CAPEX

$8.18M
SOPH annual capital expenditures is $8.18 million

CAPEX 1-year change

-11.38%
SOPH annual capital expenditures is down -11.38% year-on-year

Free Cash Flow

Free cash flow

-$51.00M
SOPH annual free cash flow is -$51.00 million

Free cash flow 1-year change

+11.77%
SOPH annual free cash flow is up +11.77% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

67.42%
SOPH annual gross profit margin is 67.42%

Operating margin

-102.14%
SOPH annual operating profit margin is -102.14%

Net margin

-95.89%
SOPH annual net profit margin is -95.89%

ROA & ROE

ROA

-34.58%
SOPH annual return on assets is -34.58%

ROE

-50.41%
SOPH annual return on equity is -50.41%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SOPH price to earnings ratio value is unknown

PE ratio Sector rank

-
SOPH price to earnings ratio is unknown

PB Ratio

PB ratio

1.99
SOPH price to book ratio is 1.99

PB ratio Sector rank

62.83%
SOPH price to book ratio is higher than 62.83% of companies in Healthcare sector

PS Ratio

PS ratio

2.95
SOPH price to sales ratio is 2.95

PS ratio Sector rank

51.41%
SOPH price to sales ratio is higher than 51.41% of companies in Healthcare sector

Enterprise value

Enterprise value

$142.28M
SOPH enterprise value is $142.28 million

Enterprise value Sector rank

53.92%
SOPH enterprise value is higher than 53.92% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.80
SOPH EV/EBITDA is -2.80

EV/EBITDA Sector rank

26.59%
SOPH EV/EBITDA is higher than 26.59% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.71
SOPH annual current ratio is 3.71

Quick ratio

3.49
SOPH annual quick ratio is 3.49

Leverage

Debt to equity

0.14
SOPH annual debt to equity ratio is 0.14

Interest coverage ratio

-31.03
SOPH annual interest coverage ratio is -31.03

Risk & Stability

Piotroski F-Score

2
SOPH piotroski f-score is 2

Altman Z-Score

-2.29
SOPH altman z-score is -2.29

Analyst ratings

Recent major analysts updates

Dec 18, 24 Craig-Hallum
Buy
Aug 7, 24 RBC Capital
Outperform
Jun 27, 24 Guggenheim
Buy
Mar 6, 24 RBC Capital
Outperform
Mar 6, 24 BTIG
Buy
Jan 12, 24 RBC Capital
Outperform
Nov 29, 23 RBC Capital
Outperform
May 10, 23 Morgan Stanley
Overweight
May 10, 23 Credit Suisse
Neutral
Mar 8, 23 Morgan Stanley
Overweight

Institutional Ownership

Similar stocks

AMRN logo
Amarin (AMRN)
ELMD logo
Electromed (ELMD)
FHTX logo
Foghorn Therapeutics (FHTX)
ANIK logo
Anika Therapeutics (ANIK)
Zhengye Biotechnology Holding Limited (ZYBT)
INGN logo
Inogen (INGN)
NVCT logo
Nuvectis Pharma (NVCT)
CDXS logo
Codexis (CDXS)
CARGO Therapeutics (CRGX)
  • What is the ticker symbol for SOPHiA GENETICS SA?
  • Does SOPHiA GENETICS SA pay dividends?
  • What sector is SOPHiA GENETICS SA in?
  • What industry is SOPHiA GENETICS SA in?
  • What country is SOPHiA GENETICS SA based in?
  • When did SOPHiA GENETICS SA go public?
  • Is SOPHiA GENETICS SA in the S&P 500?
  • Is SOPHiA GENETICS SA in the NASDAQ 100?
  • Is SOPHiA GENETICS SA in the Dow Jones?
  • When was SOPHiA GENETICS SA's last earnings report?
  • When does SOPHiA GENETICS SA report earnings?
  • Should I buy SOPHiA GENETICS SA stock now?

What is the ticker symbol for SOPHiA GENETICS SA?

The ticker symbol for SOPHiA GENETICS SA is NASDAQ:SOPH

Does SOPHiA GENETICS SA pay dividends?

No, SOPHiA GENETICS SA does not pay dividends

What sector is SOPHiA GENETICS SA in?

SOPHiA GENETICS SA is in the Healthcare sector

What industry is SOPHiA GENETICS SA in?

SOPHiA GENETICS SA is in the Health Information Services industry

What country is SOPHiA GENETICS SA based in?

SOPHiA GENETICS SA is headquartered in Switzerland

When did SOPHiA GENETICS SA go public?

SOPHiA GENETICS SA's initial public offering (IPO) was on July 23, 2021

Is SOPHiA GENETICS SA in the S&P 500?

No, SOPHiA GENETICS SA is not included in the S&P 500 index

Is SOPHiA GENETICS SA in the NASDAQ 100?

No, SOPHiA GENETICS SA is not included in the NASDAQ 100 index

Is SOPHiA GENETICS SA in the Dow Jones?

No, SOPHiA GENETICS SA is not included in the Dow Jones index

When was SOPHiA GENETICS SA's last earnings report?

SOPHiA GENETICS SA's most recent earnings report was on Mar 4, 2025

When does SOPHiA GENETICS SA report earnings?

The next expected earnings date for SOPHiA GENETICS SA is May 7, 2025

Should I buy SOPHiA GENETICS SA stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page